Endocyte, Inc. (ECYT) Tops Q4 Loss Views by 4c
Tweet
Share
E-mailGet Alerts ECYT Hot Sheet
Join SI Premium – FREE
Endocyte, Inc. (NASDAQ: ECYT) reported Q4 EPS of ($0.30), $0.04 better than the analyst estimate of ($0.34).
For earnings history and earnings-related data on Endocyte, Inc. (ECYT) click here.
For earnings history and earnings-related data on Endocyte, Inc. (ECYT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Top Wealth Group expects net profit to double in fiscal 2026
- General Mills beats estimates as cost savings offset volumes
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
